Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03901534 · ClinicalTrials.gov registry record · NA
Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 2,021
- Enrollment target
NCT03901534 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 2,021 participants.
The verdict
NCT03901534, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2,021 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether biomarkers of lung epithelial and endothelial injury are associated with obstructive sleep apnea (OSA) and interstitial lung disease (ILD).
Interventions
- DEVICE Continuous positive airway pressure (CPAP) therapy
- DEVICE Nox A1 Recorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,021 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2023-10-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03901534
The ClinicalTrials.gov registry entry for NCT03901534 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2,021 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous positive airway pressure (CPAP) therapy is the first listed.
NCT03901534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03901534 about?
NCT03901534 is a clinical study titled "Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD". The purpose of this study is to evaluate whether biomarkers of lung epithelial and endothelial injury are associated with obstructive sleep apnea (OSA) and interstitial lung disease (ILD).
What is the current status of trial NCT03901534?
This trial is currently terminated. It is a NA study. The enrollment target is 2,021 participants. The study started on 2023-01-01. Estimated completion is 2023-10-16.
What interventions are being tested in trial NCT03901534?
The interventions under investigation include: Continuous positive airway pressure (CPAP) therapy (DEVICE), Nox A1 Recorder (DEVICE).
Who is sponsoring clinical trial NCT03901534?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.